Business Context and Reporting Period
This Form 8-K Current Report was filed by Neuralstem, Inc. on February 19, 2016, regarding events occurring on February 15, 2016. The filing primarily addresses significant changes in executive leadership, the appointment of a new Chief Executive Officer (CEO), and the adoption of a new stock option plan.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data presented is limited to the compensation package for the newly appointed CEO:
- Base Salary: $440,000 per year.
- Target Annual Bonus: 50% of base salary ($220,000).
- Equity Grant: Inducement option to purchase 2,750,000 shares of Common Stock.
- Housing Allowance: Up to $5,000 per month for 12 months.
- Other Reimbursements: Commuting expenses, tax liability offsets for allowances, and up to $5,000 annually for tax/financial planning fees.
Material Changes Versus Prior Period
The filing details a material change in corporate governance and executive management:
- Departure of CEO: Richard Garr ceased serving as Chief Executive Officer, President, and General Counsel on February 15, 2016. He remains on the Board of Directors.
- Appointment of CEO: Richard Daly was appointed Chief Executive Officer, President, and Board Member effective February 15, 2016.
- Board Expansion: The Board of Directors expanded from seven to eight members to accommodate Mr. Daly's appointment.
- Unregistered Sale of Equity: The company issued an unregistered inducement option grant to Mr. Daly, exempt under Section 4(a)(2) of the Securities Act of 1933.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, revenue outlook, or management commentary regarding future business performance. The focus is strictly on the transition of leadership and the terms of the new CEO's employment. Key terms include:
- Equity Vesting: The 2,750,000 share option vests over four years (25% at 6 months, 25% at 1 year, and the remainder quarterly over the next three years).
- Severance: Mr. Daly is eligible for severance ranging from 9 to 18 months of base salary depending on the timing of termination without Cause or resignation with Good Reason.
- Change in Control: In the event of a Sale Event within 18 months, 100% of unvested equity accelerates, and a pro-rata bonus is paid.
- New Plan Adoption: The Board adopted the "Neuralstem, Inc. Inducement Award Stock Option Plan" allowing for up to 6,000,000 shares (less the grant to Mr. Daly) to be granted to new employees without shareholder approval under NASDAQ rules.
Important Facts for Investor Verification
- Verify the exact vesting schedule and exercise price of the 2,750,000 share option granted to Richard Daly.
- Confirm the total number of authorized shares under the new Inducement Award Stock Option Plan and the remaining pool available for future hires.
- Review the specific definitions of "Cause" and "Good Reason" in the Employment Agreement to understand severance triggers.
- Assess the impact of the leadership transition on the company's strategic direction, as Richard Garr is stepping down from operational roles.